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Objective:
Depression affects one in four adults with type 2 diabetes (T2DM) and is associated with worsened diabetes complications, increased health 
care costs and early mortality. Rural and low-income urban areas, including the Appalachian region, represent an epicenter of the T2DM epidemic. 
Program ACTIVE II is a comparative effectiveness treatment trial designed to test whether a combination of cognitive behavioral therapy (CBT) 
and community-based exercise (EXER) will offer greater improvements in diabetes and depression outcomes compared to individual treatment 
approaches and usual care (UC).  The secondary aims are to assess changes in cardiovascular risk factors across groups and to conduct a cost-
effectiveness analysis of predicted incidence of cardiovascular complications across groups.
Methods: 
The study is a 2-by-2 factorial randomized controlled trial consisting of 4 treatment groups: CBT alone, EXER alone, combination of CBT and 
EXER, and UC. Adults with T2DM for > 1 year and who meet DSM-IVTR criteria for Major Depressive Disorder (MDD) are eligible to participate at 
two rural Appalachian sites (southeastern Ohio and West Virginia) and one urban site (Indianapolis). This type II behavioral translation study uses 
a community-engaged research (CEnR) approach by incorporating community fitness centers and mental health practices as interventionists.
Conclusions:
This is the first study to evaluate the comparative effectiveness of combined CBT and exercise in the treatment of depression using 
community-based intervention delivery. This approach may serve as a national model for expanding depression treatment for patients with 
T2DM.
Introduction
Nearly one in 10 Americans has diabetes and current projections 
estimate diabetes will affect one in three Americans born in the year 2000 
[1] resulting in annual T2DM-related costs of $256 billion [2].  Low-
income urban and rural areas such as the Appalachian region bear a 
disproportionate burden of the national T2DM epidemic [3].  In West 
Virginia (WV), the statewide age-adjustment prevalence of diagnosed 
T2DM is 10.4% [4] while the average prevalence rate of T2DM in rural 
Appalachian Ohio (OH) counties is 11.3% [5] exceeding the national 
average of 9.3% [1]. The Appalachian region also bears a disproportionate 
burden of major depressive disorder (MDD; 8.2%) compared to non-
Appalachian areas (7.6%), with higher rates found in central Appalachian 
states (10.6%) such as WV and OH than northern or southern states [6].   
Barriers to care for T2DM and MDD in low-income urban and 
rural areas such as central Appalachia are considerable and similar. 
Decreased access to health and mental health care providers, lack of 
public transportation and rising costs for private transportation (e.g. gas 
prices) in the context of geographic isolation pose significant barriers to 
consistent and effective health and mental health care [7-8]. 
Patients with T2DM have been found to be two times more likely to 
experience depressive symptoms than their non-diabetic peers with one 
in four patients reporting clinically significant depressive symptoms and 
11.4% meeting criteria for MDD [9].
Depressive symptoms have been shown to be associated with worsened 
blood glucose levels [10] and T2DM complications [11].  In addition, 
significant functional and financial costs are associated with depression 
and T2DM including decreased adherence to diabetes care regimens[12], 
increased functional disability [13], increased health care costs without 
resulting improvements in depression or diabetes outcomes [14], 
decreased quality of life [15-16]and earlier mortality attributable to all 
causes (17-18). 
Few controlled treatment trials have been conducted to treat depression 
and T2DM [19-23].  Only three have evaluated behavioral treatment 
strategies in this population.  In a meta-analysis of 29 randomized 
controlled trials evaluating cognitive behavioral therapy (CBT) treatment 
for MDD across a continuum of disease states, a robust effect size (-.83) 
documented the efficacy of this approach [24]. In a study of 51 patients 
(mean age 53 + 10 years; 60% female) diagnosed with T2DM (mean duration 
8 years) and MDD randomly assigned to a 10-week individualized CBT or 
control condition without medication intervention,  Lustman found that 
patients receiving CBT were 3 times more likely to experience depression 
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remission at post-treatment assessment than controls [19].  Although no 
group differences in A1c levels were found at post-treatment assessment 
(adjusted for baseline values), patients in the CBT condition showed 
improvement in A1c at the 6-month follow-up assessment compared to 
controls [19]. Treatment responsiveness appeared to be associated with 
severity of depression and A1c at baseline [19,25].
In the Pathways Study, problem-solving therapy (a variation of CBT) 
was integrated within the primary care setting to treat depression in adults 
with T2DM [23].  Participants randomized to a stepped-care problem-
solving therapy intervention reported higher levels of treatment exposure, 
satisfaction with care and improved depression outcomes compared to 
patients in the usual care group.  In this study, improvements in glycemic 
control were not observed immediately following care or at 6- or 12-month 
follow-up assessments [23].Taken together; these studies demonstrate the 
efficacy of CBT in treating depression in adults with T2DMwith mixed 
results associated with changes in glycemic control.  
Exercise has the potential to directly improve glycemic outcomes in 
the context of MDD treatment and has been shown to be an efficacious 
treatment for clinical depression among adults without T2DM [26-27]. 
In a meta-analysis of 37 exercise intervention trials in clinically depressed 
samples, Craft & Landers [28]found a large overall effect size (-.72) in the 
reduction of clinical depression with the greatest impact found in samples 
with moderate-to-severe levels of depression. Exercise interventions of 9 
to12 weeks showed significantly greater impact on depression outcomes, 
but no differences were observed in the types of exercise used in treatment 
protocols. Exercise interventions have also been shown to improve 
glycemic control in patients with T2DM [29-34]. 
To date, only one randomized controlled trial (RCT) has examined 
the impact of exercise on depression in adults with type 2 diabetes. Piette 
and colleagues randomized 291 adult patients with T2DM and depressive 
symptoms (mild to severe) to 12 weeks of manualized telephone-based 
CBT (with 9 monthly booster sessions) with a walking programor 
enhanced UC [35]. At 12-month follow-up, 58% of participants in the 
intervention group had depressive symptoms fall below the mild threshold. 
Number of steps was higher and systolic blood pressure was lower in 
the intervention group at follow-up.  No changes were observed in A1c 
at the 12-month follow-up assessment [35].  The telephone-based CBT 
and walking interventions were combined and could not be evaluated for 
depression and A1c outcomes separately. 
To date, the existing literature has utilized traditional randomized 
controlled trials that make use of research or health care personnel to 
implement the interventions.  No studies have evaluated the comparative 
effectiveness of CBT and exercise by implementing these interventions 
with community fitness and mental health providers using a community-
engaged research (CEnR) approach. The challenge for health care 
providers and communities is to create depression treatment programs for 
T2DM patients that will reach the largest number of people at the lowest 
possible cost and burden to health care organizations.  Program ACTIVE 
II has been designed to create a model program of community-based 
depression treatment using a CEnR design that may be disseminated 
and adopted nationally.  Central to this model is the assumption that 
effective depression treatment requires multiple avenues of access beyond 
the formal health care system and multiple approaches to depression 
treatment such as CBT and exercise. Program ACTIVE II has been 
designed to simultaneously achieve two overarching goals: 1) to test the 
comparative effectiveness of the cognitive behavioral therapy (CBT) and 
community-based exercise (EXER) to usual care (UC); and 2) to develop 
a sustainable program that may be used as a scalable model for T2DM and 
depression treatment for national dissemination.  The research team has 
partnered with community mental health providers and exercise facilities 
to implement the intervention.   This paper reports on the innovative 
design and methodology of this large-scale multi-site trial. 
Research Design and Methods
Program ACTIVE II is a 2-by-2 factorial repeated measures RCT 
design. The study is a multi-center trial in 3 states designed to maximize 
generalizability of the findings across high risk groups in both urban and 
rural areas to assess outcomes and to build the infrastructure necessary to 
achieve a sustainable program. Program ACTIVE II uses a community-
engaged research (CEnR) approach in which community organizations 
are engaged in all aspects of the study:  recruitment, intervention 
implementation, and dissemination of findings.  This approach confers 
additional validity to the study outcomes by examining the effectiveness 
of the intervention in the sites where they are ultimately designed to take 
place and demonstrated stakeholder commitment to the intervention 
which serves as a foundation for the ultimate adoption of the Program 
ACTIVE intervention beyond the period of federal funding.
The purpose of Program ACTIVE II is to address two primary aims: 
1) to compare changes in glycemic control across individual intervention 
groups to usual care (UC) at post-intervention (POST) and 6- and 
12-month follow-up assessments; and 2) to compare changes in MDD 
outcomes across individual intervention groups to UCat POST and 6- 
and 12-month follow-up assessments. The study will also address two 
secondary aims:  1) to compare changes in cardiovascular risk factors (e.g. 
LDL cholesterol) across individual groups to UC at each of the 3 time 
points; and 2) to calculate the cost-effectiveness of each treatment arm in 
terms of predicted incidence of cardiovascular complications over a 10-
year period. 
Sample size 
Based on our pilot study [36] and a meta-analysis by Boule et al., we 
used a conservative assumption of a mean (SD) difference of 0.6% (1.4%) 
in improving A1c between the UC and exercise groups at post intervention 
[29].Using a sample size of 43 in each of the four treatment groups will 
have 80% power to detect the main effect of exercise. However, we will 
recruit 54 per group assuming a 20% dropout rate.
In estimating the sample size to detect changes in MDD outcomes, 
we assumed 60% and 30% remission rates for the CBT and UC groups, 
respectively, at post intervention [19]. Using a sample size of 43 in each of 
the four treatment groups will have 97% power to detect the main effect 
of CBT.
Randomization
A site-specific computer generated randomization list was used to 
randomly assign study subjects to one of the four treatment groups. 
A block size of four was used to ensure balance in number of subjects 
recruited in four groups after recruiting every four subjects. 
Characteristics
Inclusion/Exclusion Criteria:  Inclusion criteria: age 18 or older, 
ambulatory status, diagnosis of T2DM for one year duration or longer, 
major depression lasting 2 weeks or longer with no evidence of psychotic 
symptoms. Medical exclusion criteria include: history of diabetic 
ketoacidosis (DKA), continuous insulin therapy since T2DM diagnosis, 
stage 2 hypertension as defined by JNC VII, recent cardiac events (e.g. 
unstable angina, diagnosed angina, PTCA, any cardiac intervention 
for CAD or tachydysrhythmias in the past 6 months), laser surgery for 
proliferative retinopathy in the past 6 months, history of stroke, lower 
limb amputation, asensory peripheral neuropathy, aortic stenosis or other 
severe valvular heart disease, atrial fibrillation, severe COPD (e.g., basal 
oxygen), class III or IV heart failure or medical instability.   Psychiatric 
exclusion criteria include: active suicidal ideation or a history of suicide 
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attempt, bipolar depression or history of psychotic disorder and current 
substance abuse or dependence disorder. Participants who are currently 
prescribed antidepressant medications for 6 weeks or longer and who 
meet diagnostic criteria for major depression without psychotic features 
are included.
Participants who report the use of a current antidepressant medication 
for 5 weeks or less are excluded or deferred for later screening after the 
6-week period.  Participants who are currently receiving psychotherapy 
from a mental health provider for MDD are excluded. Participants who 
are currently receiving only medication management from a psychiatrist 
are included. Respondents who meet eligibility criteria are invited to 
participate in the baseline screening assessment and referred to their local 
site PI.
Recruitment
Participants are recruited from communities served by the 3 
intervention areas: Indianapolis, southeastern Ohio/western West Virginia 
and north central West Virginia.  Advertising takes place via physician 
offices, newspapers, radio stations, community centers, partnering 
community organizations and community events. In addition, patients of 
partner medical practices are contacted by phone to receive information 
about the study and to inquire about interest and eligibility (IU and WV). 
The recruitment flow chart is shown in Figure 1 (below).Individuals are 
screened by telephone by trained study staff to determine initial eligibility. 
Once eligible via phone screen, participants are scheduled for a baseline 
assessment visit where the informed consent takes place. Medical and 
psychiatric data from the baseline assessment are reviewed by the study 
or site medical directors (JS. FS, KF, KM), exercise physiologist (GH) and 
PI (MdG) as a group to determine eligibility for study enrollment. Eligible 
participants are then randomly assigned to one of the four groups: CBT, 
EXER, CBT+EXER or UC.
Assessment procedures
Psychological, behavioral and physiologic measures are administered 
at each assessment period: baseline, post-intervention, 6- and 12-month 
follow-up with the exception of demographic characteristics (baseline 
only).  Measures are shown in Table 1. 
At the beginning of the baseline assessment visit, individuals are 
consented to participate in the study by the Site PI or project coordinator. 
Baseline assessment includes the medical history interview, blood draws, 
anthropometric measurements and fitness assessment.  Participants 
are given a pedometer, food and activity diaries and questionnaires 
to complete following the baseline assessment. Participants complete 
psychosocial measures at home (returned by mail) and complete a SCID 
Axis I interview by phone.  The core investigator team, site PIs and 
project coordinators conduct weekly teleconferences to review all data 
following baseline assessment. Participants who meet all study criteria are 
randomized to one of the four intervention groups, scheduled for a free 
nutritional education program and their first intervention session (CBT, 
EXER or CBT+EXER) the following week. 
Interventions
The active interventions in Program ACTIVE II are 12-weeks of 
community-based exercise and 10 individual sessions of CBT. In order to 
facilitate diabetes education and to offer an incentive to UC participants, 
Dining with Diabetes nutrition classes are provided to participants in 
all arms. Based on prior studies, nutrition education is not expected to 
influence depression outcomes [19]. 
CBT Intervention:  CBT has gained wide acceptance as an efficacious 
intervention approach for the treatment of depression [50]. CBT posits 
that cognitions, emotions and behaviors are interwoven and mutually 
reinforcing in the depressed patient [50]. Treatment involves the 
identification and reframing of “automatic thoughts” (i.e., cognitive 
biases) that work in the service of depressogenic core cognitive beliefs [50]. 
Cognitive biases and core beliefs are empirically tested and restructured. 
Behavioral techniques, such as increasing daily activity and development 
and interaction with social support networks are interwoven into CBT 
therapy [50]. The use of cognitive and behavioral tools modeled in therapy 
and generalized by the participant through take home activities provides 
participants with an opportunity to generalize skills to situations beyond 
the therapeutic relationship. 
CBT sessions are conducted by trained licensed mental health providers 
currently in practice in their respective communities.  They represent the 
range of practice environments from individual private practitioners to 
community mental health centers. Participants receive 10 sessions of 
CBT using the manualized approach based on Beck’s model of cognitive 
therapy [50].Sessions are scheduled weekly over the course of the 12-
week period. In light of the large array of skills that are possible to include 
in the CBT framework, selected goals have been targeted for our brief 
therapy format (presentation of CBT model; thought records, cognitive 
distortions, counterarguments, cognitive reframing, automatic thoughts, 
core beliefs, and relapse prevention).  CBT therapists receive training in 
CBT and manualized training approach from the study team.
Exercise Intervention: The exercise protocol is a community-based 
exercise intervention based on the aerobic exercise goals adapted from the 
Lifestyle Balance behavior arm of the DPP [44]. Partner exercise facilities 
represent a range of fitness facilities including physical therapy practices, 
community centers and for-profit and non-profit fitness organizations 
(e.g. YMCA). Trained instructors at each facility provide 6 classes of 
monitored instruction on exercise to participants to meet heart rate and 
activity-level goals. Membership to the centers is provided to participants 
free of cost throughout the 12-week intervention period. Passes to fitness 
Local advertising 
IUSM phone screening 
1 of 3 Sites: 
Randomization to Intervention 
 
Medical assessment 
Psychiatric Interview 
Eligible Referred to current 
physician for stress test? 
Eligible 
No approval 
Ineligible 
Physician 
approval 
Deferred Ineligible 
Figure 1: Recruitment Flow Chart
Separate randomization lists were generated by the study statistician 
for use by each study site.
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facilities and costs for time spent with the fitness trainer are purchased by 
the grant to increase access to exercise for the duration of the protocol. 
These costs replicate costs of the program to community members of an 
independent program.
Exercise goals are adapted to accommodate the physical and medical 
restrictions of an older-adult T2DM population. Exercise prescriptions 
are based on the results obtained from the baseline 6MWT. Participants 
are given exercise goals of performing 150 minutes per week of moderate 
activity at 40- <60% of heart rate reserve (HRR), comparable to a Rating 
of Perceived Exertion of 11-13. These goals may be modified based on 
results of the 6 Minute Walk Test (6MWT). Due to high rates of sedentary 
behaviors in this population, physical activity goals are increased in a 
graduated fashion during Weeks 1-3, beginning with 100 minutes of 
weekly aerobic exercise to 150 minutes of total aerobic weekly exercise 
by Weeks 4-12 [47]. Intensity of activity begins at 40% in Week 1 and 
progresses as tolerated, but continues to remain below 60% of HRR.
In order to provide participants with the necessary training to begin 
a safe exercise program, exercise classes are taught by trained fitness 
instructors at each exercise site in Weeks 1-4 and again in Weeks 6 and 8. In 
Week 1, participants are introduced to the proper use of exercise equipment 
and the exercise prescriptions. During these sessions, participants are 
monitored for 50-minutes of exercise by the exercise fitness instructor. 
Participants are trained to exercise in a manner consistent with ACSM 
recommendations including 10 minutes of pre-activity (warm-up and 
stretching), 30 minutes of active exercise (endurance), and 10 minutes of 
post-activity (cool down, recovery) [47,51]. Participants receive feedback 
throughout the 50-minute session on their intensity for each given activity. 
Heart rate and blood pressure are measured at rest, at peak activity level, 
and following recovery. Participants are trained to utilize the Borg Scale 
[52] during their activity to monitor exercise intensity.  
In Weeks 2-4, participants are given personalized instruction on 
exercise modes available including walking on a track, use of treadmills and 
stationary recumbent/ upright ergometers consistent with the equipment 
of each fitness location. In weeks 6 and 8, participants attend an in-person 
booster session at their local exercise center to re-establish the appropriate 
exercise intensity and assess exercise technique. Exercise prescriptions 
may be adjusted at this time based on the information obtained about 
exercise intensity.  At each class, a chapter from the Program ACTIVE 
II Exercise Manual is provided to participants.  Adapted from the DPP 
Lifestyle Balance intervention materials, the manual is designed to 
address psychological barriers associated with physical activity (e.g. social 
support, motivation, behavioral goals). 
Participants are asked to complete weekly exercise diaries and to record 
number of steps measured using pedometers provided by the study (Weeks 
1-12) on paper or in electronic form through the website. Participants are 
contacted bi-weekly by a member of the study team to review information 
from activity diaries and pedometers and to evaluate any exercise-related 
medical concerns including: hyperglycemia, hypoglycemia, joint pain, 
back pain, angina, lightheadedness, and symptoms of hypotension. Data 
from participants who report medical symptoms resulting from exercise 
will be shared with the Medical Director for the respective site. The 
development of severe adverse events is communicated to the site Medical 
Director, Data Safety and Monitoring Panel and hosting IRB offices 
for consultation. SMBG data is downloaded electronically to examine 
significant changes in daily blood sugars as a result of exercise. Participants 
who show increased instances of hyper- or hypoglycemia are contacted by 
the project coordinator and advised to contact their primary care provider 
for assessment of medications. Participants are provided with electronic 
(via website) and paper (as needed) supplemental adherence materials 
(i.e. toolkit) such as walking maps, self-care information, and games to 
promote adherence. 
Nutrition Intervention:  In order to evaluate the effectiveness of the 
target interventions in the context of T2DM treatment best practices, 
Measures Screening Baseline POST
6- and 12-
Mo. Follow-
Up
Outcome 
Variable Covariate
Clinical 
Monitoring 
Variable
Psychosocial
Demographic Characteristics X X
Structured Clinical Interview for the DSM-
IVTR (SCID Axis I Disorders) X (Screener)
X
Lifetime
X
Current
X
Current
Primary
Beck Depression Inventory (BDI) X X X Primary
Diabetes Quality of Life (DQOL) X X X Secondary
SF-36 Quality of Life Measure X X X Secondary
Chronic Illness Resource Survey (CIRS) X X X Secondary
Behavioral
Physical Activity Diary (1 week) X X X X
Pedometer  (1 week) X X X X
Physiologic
Glycated Hemoglobin (A1c) X X X Primary
Blood lipid profile (HDL-C; triglycerides) X X X Secondary
Self-Monitored Blood Glucose (SMBG) X X X X
Medical History Interview X X
Medical Status Review X X X
6-Minute Walk Test X X X Secondary
Height X X X X
Weight X X X X
Waist/Hip Girth X X X
Blood Pressure X X X Secondary X
Resting Heart Rate/Pulse X X X X
Perceived Exertion (Borg rating) X X X X
Table 1:  Administration of Assessment Measures in Program ACTIVE
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participants in all 4 groups are provided classes in the Dining with 
Diabetes (DWD) program through The Ohio State University, West 
Virginia University Extension or Purdue University Marion County 
Extension. 
Statistical analyses
The intention-to-treat principle will be used for all analyses. 
Differences in participants’ baseline characteristics among 4 groups will 
be evaluated by ANOVA or the nonparametric Kruskal-Wallis test for 
continuous outcomes and by Chi-square test for categorical outcomes. A 
mixed-model analysis of variance including site, treatment group, time, 
gender, race, age, baseline value of A1c will be used to assess the effects of 
exercise on A1c at post-intervention, 6- and 12-month.  Participants will 
be treated as a random effect and a un-structure covariance matrix will be 
used. The dichotomous primary outcome, remission in depression, will be 
analyzed by a non-linear mixed-effects model and will adjust for potential 
confounder’s gender, race, age and baseline depression score. In each of 
the above two models, an interaction effect between time and treatment 
group will be assessed first. If there is no interaction effect, the overall 
treatment difference will be assessed. Otherwise, treatment difference 
will be assessed at each time point. The model will be fitted by the SAS 
procedure NLMIXED. 
Secondary Outcomes 
Functional exercise status and cardiovascular risk factors: A 
repeated measures ANCOVA will be conducted to assess changes in 
highest HR during the 6 minute walk test, distance achieved, LDL-C, 
HDL-C, triglycerides, and resting blood pressure from baseline to POST 
and baseline to the 6- and 12-month assessments. 
Cost-effectiveness (CE) analyses: A Markov decision model of type 
2 diabetes progression to complications will be constructed using cost 
data collected at baseline, post-intervention, 6 and 12 months of follow-
up.  Short- and long-term effects of the intervention can be estimated by 
including time horizons 3, 10, 20 and lifetime in the Markov model. All 
costs will be adjusted to the year 2007 using the US Consumer Price Index.
Markov models: We will develop a Markov decision model with 
sensitivity analyses to estimate the Incremental Cost-Effectiveness ratio 
(ICER)   of the intervention compared to UC as implemented in Program 
ACTIVE II. An ICER is computed by the ratio of ΔC/ΔE where ΔC 
represents the change in cost due to the intervention compared with UC 
and ΔE represents the change in health benefits due to the intervention 
compared with UC.  We will use TreeAge Pro Suite 2009 software (TreeAge 
Software, Williamstown, MA).  The model will directly incorporate 
intervention effectiveness and cost data as well as event probabilities from 
the RCT to estimate life expectancy, quality-adjusted life-expectancy 
(expressed as QALYs), clinical outcomes (diabetes complications), and 
direct medical and nonmedical costs associated with the interventions 
and UC. 
Data Safety and Monitoring Panel
A Data Safety and Monitoring Panel (DSMP) were created to provide 
expert consultation in the primary disciplines involved in the content 
of the study:  psychology, medicine, and exercise physiology.  These 
consultants provide input on issues such as metabolic or physiological 
changes in participants during participation, mental status of participants, 
and implementation of the exercise protocol throughout Program 
ACTIVE II.  Members of the panel are available for consultation for issues 
of research ethics, clinical care, and human subject’s protection.  Members 
of the panel are independent from the research team to ensure objectivity 
in the treatment of participants. 
Data integrity is reviewed by the Core Investigators in consultation 
with Dr. Chandan Saha of the IUSM Department of Biostatistics.  The 
Core Investigators meet monthly by phone to discuss issues related to 
recruitment, implementation of the intervention, participant safety, and 
to monitor data trends (e.g., adherence, missing data.
Conclusions
T2DM and co-morbid depression represents a growing challenge to 
patients and health care systems as the prevalence of both disorders rises 
but access to treatment remains limited.  In this study, we are investigating 
the comparative effectiveness of a combination of CBT and exercise using 
a CErN approach in which community fitness and mental health partners 
provide depression treatment to study participants.  This approach is novel 
because it is the first study to examine the comparative effectiveness of two 
behavioral treatment approaches to depression and T2DM.  Moreover, it 
leverages community resources such as fitness centers, community centers 
and community mental health professionals that already exist in rural and 
low-income urban communities to serve as treatment partners to health 
care centers.   At the same time, it expands knowledge of diabetes treatment 
issues to these community providers thereby expanding continuity of care 
for participants.
Data from this study will provide the empirical foundation for 
community stakeholders to evaluate the value of this program in terms 
of health and mental health outcomes in their communities and to 
identify the ways that this may become a sustainable treatment resource 
for communities beyond the period of federal funding.   Lessons learned 
from this study will also inform the dissemination of this intervention as a 
model that may be scaled to the national level to alleviate the burden and 
costs with this important set of disorders. 
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